Home » Topics » BioWorld Science

BioWorld Science
RSS

Characterization of potent and selective inhibitors of BET BD2

Sep. 23, 2021

NanoViricides reports preclinical data on NV-CoV-2-R

Sep. 23, 2021

Preclinical evaluation of novel mAChR subtype-selective M1 PAMs

Sep. 23, 2021

Immunic signs license agreement for DHODH inhibitors and nucleoside analogues for viral infections

Sep. 23, 2021

Compound from a new class of antimalarials shows activity in vitro and in vivo

Sep. 23, 2021

MIPS-521 exerts analgesic efficacy through stabilization of GPCR-G protein complex dynamics

Sep. 23, 2021

BeiGene discovers non-receptor tyrosine-protein kinase TYK2 inhibitors

Sep. 23, 2021

ShanghaiTech University describes IKZF1/IKZF3 degradation inducers

Sep. 23, 2021

New IL-17 modulators identified at UCB

Sep. 23, 2021

Shanghai Zheye Biotechnology patents G12C mutant GTPase KRAS inhibitors

Sep. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...